Professor Vallance's editorial (June 2002 JRSM 1 ) will be considered by most of your readers to be a well-balanced discussion on the use of animals in research. I too would agree with most of this article, were it not for the fact that I was trained as a veterinary surgeon who is acutely aware of the concept of species differences, not only between horses and canaries, but also between mice and men. However, most of my knowledge on the subject is the result of private research. I therefore believe that the reason 'the medical profession as a whole has remained rather quiet' is simply that most doctors have not made an in-depth study of the subject at hand. Most doctors do not know that the chimpanzees (our closest living relatives, with whom we share 98.4% of our DNA) are resistant to HIV, hepatitis B and common malaria. Similarly, most are not aware of the fact that humans are the only mammals who lack sialic acid on their cell surfaces, which represents a major obstacle to xenotransplantation (animal to human organ transplants), in addition to the other risks inherent in such transplants 2 .
The 3 Rs approach (replacement, reduction and refinement) is already out of date. This approach represents the old science of empiricism, based largely on experimentation and observation. The past 15-20 years have produced something of a scientific revolution, in terms of exact science. Is it really still necessary to perform toxic risk assessment on rodents and dogs, when we can observe the damaging effects of a chemical substance in human cell culture, at the molecular level?
The elucidation of the human genome clearly underlines the physiological differences between human individuals, let alone those between humans and animals. The way forward is individualized medicine, where patients will receive medication based on their genetic profile, thereby reducing the risk of adverse drug reactions which now rank as the fourth leading cause of death in western hospitals 3 . It should of course be noted that the medical drugs which are responsible for this virtual epidemic of adverse drug reactions were all thoroughly tested on laboratory animals, as is required by law. Does this sad statistic not say something about our regulatory system? 
Management of testicular torsion
Mr Pearce and his colleagues (May 2002 JRSM 1 ) propose a protocol for management of suspected testicular torsion, based on their observations of clinical practice in the North West of England. They recommend fixation with delayedabsorption or non-absorbable sutures. There is, however, much controversy surrounding the method used for testicular fixation when a torted testis is deemed salvageable. Sutureless dartos muscle pouch fixation is a technique which is now increasingly being used by urologists and paediatric surgeons 2 . The main reason for this is that fixation with sutures, which traverse the blood-testis barrier, can generate an autoimmune response that leads to eventual infertility 3 . Suture fixation has additional complications. Non-absorbable sutures are associated with the formation of microabscesses and granulomas, predisposing to chronic testicular pain 4 , whilst absorbable sutures result in only fine adhesions at the site of placement and thus increase the risk of recurrent torsion 5 . Is suture fixation actually necessary? Eversion of the tunica vaginalis, as is performed in a Jaboulay procedure for hydrocele, leads to the formation of satisfactory adhesions and aids in the prevention of future torsion 6 . In conclusion, eversion of the tunica vaginalis together with sutureless fixation in a dartos pouch probably provides the best method of fixation.
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